RNS Number : 5703Q
Seraphim Space Investment Trust PLC
19 October 2023
 

SERAPHIM SPACE INVESTMENT TRUST PLC

 

("the Company" or "SSIT")

 

 

The Company announces that its Annual General Meeting ("AGM") will be held at 1 Fleet Place, London, EC4M 7WS (GPS postcode: EC4M 7RA) at 12.00 p.m. on 20 November 2023.

The Notice of AGM has been dispatched to shareholders. An electronic copy of the Notice of AGM is also available on the Company's website https://investors.seraphim.vc/.

 

A copy of the Notice and Form of Proxy can be inspected at the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

- Ends -

 

Media Enquiries

Seraphim Space Manager LLP (via SEC Newgate)
 Mark Boggett, CEO / James Bruegger, CIO / Rob Desborough           

SEC Newgate (Communications advisers)                                        seraphim@secnewgate.co.uk 
 Emma Kane / Clotilde Gros / George Esmond                                                  +44 (0) 20 3757 6767
 

Deutsche Numis
 Mark Hankinson / Gavin Deane / Neil Coleman                                               +44 (0) 20 754 58000
 

J.P. Morgan Cazenove
 William Simmonds / Jérémie Birnbaum / Rupert Budge                                  +44 (0) 20 7742 4000
 

Ocorian Administration (UK) Limited                                              seraphimteam@ocorian.com 

Lorna Zimny                                                                                                         +44 7387 971915

 

Notes to Editors:

About Seraphim Space Investment Trust

Seraphim Space Investment Trust plc (the "Company" or "SSIT) is the world's first listed fund focused on SpaceTech. The Company seeks exposure predominantly to early and growth stage private financed SpaceTech businesses that have the potential to dominate globally and that are sector leaders with first mover advantages in areas such as climate, communications, mobility and cyber security.

 

The Company is listed on the Premium Segment of the London Stock Exchange. Further information is available at:  https://investors.seraphim.vc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOANKFBDQBDDNKD